Society guideline links: Dyspnea

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Chronic obstructive pulmonary disease".)

●(See "Society guideline links: Asthma in adolescents and adults".)

●(See "Society guideline links: Asthma in children".)

●(See "Society guideline links: Severe asthma in adolescents and adults".)

●(See "Society guideline links: Occupational asthma".)

●(See "Society guideline links: Adult with chest pain in the emergency department".)

Canada

●Choosing Wisely Canada: Don't initiate long-term maintenance inhalers in stable patients with suspected COPD if they have not had confirmation of post-bronchodilator airflow obstruction with spirometry (2022)

●Choosing Wisely Canada: Don't use oxygen therapy to treat non-hypoxic dyspnea (2021)

●BC Cancer: Symptom management guidelines ─ Dyspnea (2010, revised 2019)

●Cancer Care Ontario (CCO): Guidelines on management of dyspnea (breathlessness) in patients with cancer (2019)

●Canadian Thoracic Society (CTS): Clinical practice guideline on managing dyspnea in patients with advanced COPD (2011)

United States

●American College of Physicians (ACP): A clinical guideline on appropriate use of point-of-care ultrasonography in patients with acute dyspnea in emergency department or inpatient settings (2021)

●American College of Radiology (ACR): ACR Appropriateness Criteria dyspnea-suspected cardiac origin (2021)

●American Society of Clinical Oncology (ASCO): Guideline for management of dyspnea in advanced cancer (2021)

●ACR: ACR Appropriateness Criteria on acute respiratory illness in immunocompromised patients (2019)

●ACR: ACR Appropriateness Criteria on acute respiratory illness in immunocompetent patients (2018)

●ACR: ACR Appropriateness Criteria on chronic dyspnea ─ Suspected pulmonary origin (2018)

●ACR: ACR Appropriateness Criteria on chronic dyspnea-noncardiovascular origin (2018)

●National Consensus Project (NCP): Clinical practice guidelines for quality palliative care, 4th edition (2018)

●Improving Palliative Care in the ICU (IPAL-ICU): A report on palliative care in the ICU – Relief of pain, dyspnea, and thirst (2014)

●American Thoracic Society (ATS): Official statement – Mechanisms, assessment, and management of dyspnea, update (2012)

Europe

●European Society for Medical Oncology (ESMO): Clinical practice guidelines for the management of breathlessness in patients with cancer (2020)

United Kingdom

●Scottish palliative care guidelines on breathlessness (2013, updated 2020)

Australia–New Zealand

●Choosing Wisely Australia: Do not use oxygen therapy to treat non-hypoxic dyspnoea (reviewed 2016)

Japan

●Japanese Society for Palliative Medicine (JSPM): Intensive palliative care for delirium, dyspnea, and pain ─ Before the diagnosis of the symptoms as being refractory (2019)